Slocum, Gordon & CO LLP Portfolio Holdings

Slocum, Gordon & CO LLP

  • $115 Million
  • Q4 2024

Slocum, Gordon & CO LLP has filed its 13F form on January 28, 2025 for Q4 2024 where it was disclosed a total value porftolio of $115 Million distributed in 137 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Merck & Co., Inc. with a value of $9.73M, Procter & Gamble CO with a value of $8.71M, Exxon Mobil Corp with a value of $8.12M, Johnson & Johnson with a value of $6.85M, and Abb Vie Inc. with a value of $6.81M.

Examining the 13F form we can see an decrease of $397M in the current position value, from $512M to 115M.

Slocum, Gordon & CO LLP is based out at Newport, RI

Below you can find more details about Slocum, Gordon & CO LLP portfolio as well as his latest detailed transactions.

Portfolio value $115 Million
Healthcare: $28.5 Million
Consumer Defensive: $18.3 Million
Energy: $16 Million
Utilities: $15.6 Million
Communication Services: $7.89 Million
Industrials: $6.61 Million
Technology: $5.88 Million
Financial Services: $5.72 Million
Other: $10.1 Million

Stock Holdings Table Companies Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$227B
$9.73 Million 8.48% of portfolio
97,762
Q4 2024 Reduced 1.79%
$401B
$8.71 Million 7.59% of portfolio
51,966
Q4 2024 Reduced 2.46%
$458B
$8.12 Million 7.08% of portfolio
75,453
Q4 2024 Reduced 0.88%
$404B
$6.85 Million 5.97% of portfolio
47,349
Q4 2024 Reduced 4.55%
$339B
$6.81 Million 5.94% of portfolio
38,317
Q4 2024 Reduced 4.62%
$51.1B
$6.46 Million 5.63% of portfolio
70,015
Q4 2024 Reduced 2.62%
$25B
$5.53 Million 4.82% of portfolio
170,387
Q4 2024 Reduced 1.94%
$169B
$5.23 Million 4.56% of portfolio
130,835
Q4 2024 Reduced 5.55%
$793B
$3.99 Million 3.48% of portfolio
16,644
Q4 2024 Reduced 0.6%
$69.3B
$3.53 Million 3.08% of portfolio
65,277
Q4 2024 Reduced 2.39%
$87.7B
$3.32 Million 2.89% of portfolio
30,790
Q3 2024 Reduced 4.15%
$148B
$3.05 Million 2.66% of portfolio
115,106
Q4 2024 Reduced 24.33%
$22.5B
$2.98 Million 2.6% of portfolio
105,805
Q4 2024 Reduced 7.14%
$43.6B
$2.72 Million 2.37% of portfolio
20,789
Q4 2024 Reduced 1.35%
$174B
$2.5 Million 2.18% of portfolio
109,797
Q4 2024 Added 5.11%
$4.41B
$2.17 Million 1.89% of portfolio
109,333
Q4 2024 Reduced 2.46%
$236B
$1.98 Million 1.72% of portfolio
8,985
Q3 2024 Reduced 0.5%
$224B
$1.91 Million 1.67% of portfolio
11,458
Q4 2024 Reduced 0.54%
$22.4B
$1.89 Million 1.65% of portfolio
57,776
Q4 2024 Reduced 10.16%
$3.74T
$1.88 Million 1.64% of portfolio
7,508
Q4 2024 Reduced 0.37%
$84.3B
$1.83 Million 1.6% of portfolio
14,212
Q3 2024 Reduced 0.7%
$44.1B
$1.77 Million 1.54% of portfolio
35,827
Q4 2024 Reduced 4.72%
$3.08T
$1.49 Million 1.3% of portfolio
3,541
Q3 2024 Reduced 16.86%
$148B
$1.29 Million 1.13% of portfolio
22,775
Q4 2024 Reduced 18.86%
$278B
$1.07 Million 0.93% of portfolio
11,874
Q4 2024 Reduced 0.71%
$150B
$1.06 Million 0.92% of portfolio
4,637
Q2 2024 Added 2.84%
$189B
$906,000 0.79% of portfolio
2,500
Q4 2024 Added 400.0%
$38.6B
$903,000 0.79% of portfolio
11,854
Q3 2024 Reduced 0.54%
$12B
$866,000 0.75% of portfolio
31,230
Q4 2024 Reduced 10.03%
$424B
$732,000 0.64% of portfolio
1,883
Q1 2023 Reduced 1.86%
$2.41T
$548,000 0.48% of portfolio
2,499
Q3 2024 Reduced 0.68%
$616B
$542,000 0.47% of portfolio
1,197
Q3 2024 Added 9.12%
$26.7B
$512,000 0.45% of portfolio
12,778
Q3 2024 Reduced 0.5%
$231B
$480,000 0.42% of portfolio
4,250
Q1 2024 Reduced 9.57%
$35.3B
$480,000 0.42% of portfolio
7,540
Q2 2024 Added 4.72%
$201B
$353,000 0.31% of portfolio
2,326
Q3 2024 Reduced 1.06%
$82.2B
$316,000 0.28% of portfolio
1,942
Q2 2023 New
$15.3B
$321,000 0.28% of portfolio
2,660
Q4 2024 Reduced 99.52%
$311B
$323,000 0.28% of portfolio
2,410
Q3 2024 Added 51.57%
$165B
$293,000 0.26% of portfolio
1,125
Q1 2023 Reduced 5.6%
$57.7B
$301,000 0.26% of portfolio
1,250
Q3 2023 New
$228B
$285,000 0.25% of portfolio
549
Q4 2024 Reduced 4.36%
$127B
$274,000 0.24% of portfolio
4,854
Q2 2024 Added 8.01%
$967M
$272,000 0.24% of portfolio
23,087
Q2 2023 New
$299B
$224,000 0.2% of portfolio
1,547
Q4 2023 Added 14.85%
$203B
$221,000 0.19% of portfolio
1,840
Q4 2024 Added 0.11%
$240B
$213,000 0.19% of portfolio
718
Q2 2024 Added 51.8%
$212B
$199,000 0.17% of portfolio
688
Q2 2024 Added 6.5%
$71.2B
$195,000 0.17% of portfolio
833
Q2 2023 New

Summary

  • Portfolio
  • No. of Stocks 137
  • Current Value $115 Million
  • Prior Value $512 Million
  • Filing
  • Period Q4 2024
  • Filing Date January 28, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 7 stocks
  • Additional Purchases 5 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 34 stocks
Track This Portfolio

Track Slocum, Gordon & CO LLP Portfolio

Follow Slocum, Gordon & CO LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Slocum, Gordon & CO LLP, based on Form 13F filings with the SEC.

News

Stay updated on Slocum, Gordon & CO LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email